ConductScience.org, home

Paper28041832

Design, synthesis and antibacterial activities of thiouracil derivatives containing acyl thiourea as SecA inhibitors.

Cui P and 5 others. Bioorg Med Chem Lett, 2017. Cited by 20 papers, by iCite.

Cite this record

ConductScience Library. Design, synthesis and antibacterial activities of thiouracil derivatives containing acyl thiourea as SecA inhibitors. Papers, record 28041832. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28041832

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Design, synthesis and antibacterial activities of thiouracil derivatives containing acyl thiourea as SecA inhibitors.
PubMed
Journal
Bioorg Med Chem Lett
PubMed
Year
2017
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
20
iCite
Relative citation ratio, by iCite
1
iCite
Revised in PubMed
2019-12-10
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cui PPenglei
2Li XXiaoliu
3Zhu MMengyuan
4Wang BBinghe
5Liu JJing
6Chen HHua

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adenosine TriphosphatasesMajor topic
Anti-Bacterial AgentsMajor topic
Bacterial ProteinsMajor topic
Drug DesignMajor topic
Enzyme InhibitorsMajor topic
SEC Translocation ChannelsMajor topic
ThiouracilMajor topic
Bacillus amyloliquefaciens
Bacillus subtilis
Binding Sites
Microbial Sensitivity Tests
Molecular Docking Simulation
Protein Structure, Tertiary
SecA Proteins
Staphylococcus aureus

Source PubMed

Download CSV of topics

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.

PMIDTitleJournalYearIn PapersSource
42707565Synthesis, structure and computational study of N-acetyl-N'-(4-chloro-phen-yl)-thio-urea.Acta Crystallogr E Crystallogr Commun2026https://conductscience.org/library/papers/42707565PubMed
38900333Towards new bioactive fluorine-containing 1,3,4-oxadiazole-amide derivatives: synthesis, antibacterial activity, molecular docking and molecular dynamics simulation study.Mol Divers2025https://conductscience.org/library/papers/38900333PubMed
37237710New N-acyl Thiourea Derivatives: Synthesis, Standardized Quantification Method and In Vitro Evaluation of Potential Biological Activities.Antibiotics (Basel)2023https://conductscience.org/library/papers/37237710PubMed
37049981Evaluation of Antibacterial Activity of Thiourea Derivative TD4 against Methicillin-Resistant Staphylococcus aureus via Destroying the NAD+/NADH Homeostasis.Molecules2023https://conductscience.org/library/papers/37049981PubMed
36985680Investigation of Newly Synthesized Bis-Acyl-Thiourea Derivatives of 4-Nitrobenzene-1,2-Diamine for Their DNA Binding, Urease Inhibition, and Anti-Brain-Tumor Activities.Molecules2023https://conductscience.org/library/papers/36985680PubMed
36838913Novel 2-Thiouracil-5-Sulfonamide Derivatives: Design, Synthesis, Molecular Docking, and Biological Evaluation as Antioxidants with 15-LOX Inhibition.Molecules2023https://conductscience.org/library/papers/36838913PubMed
36232944Analysis of 1-Aroyl-3-[3-chloro-2-methylphenyl] Thiourea Hybrids as Potent Urease Inhibitors: Synthesis, Biochemical Evaluation and Computational Approach.Int J Mol Sci2022https://conductscience.org/library/papers/36232944PubMed
34841164Single-Crystal Investigation, Hirshfeld Surface Analysis, and DFT Study of Third-Order NLO Properties of Unsymmetrical Acyl Thiourea Derivatives.ACS Omega2021https://conductscience.org/library/papers/34841164PubMed
33914211Synthesis, antifungal activity and 3D-QSAR study of novel acyl thiourea compounds containing gem-dimethylcyclopropane ring.Mol Divers2022https://conductscience.org/library/papers/33914211PubMed
32831951Synthesis of 3(2)-phosphonylated thiazolo[3,2-a]oxopyrimidines.Beilstein J Org Chem2020https://conductscience.org/library/papers/32831951PubMed
32100245Synthesis, characterization, antimicrobial, antioxidant and computational evaluation of N-acyl-morpholine-4-carbothioamides.Mol Divers2021https://conductscience.org/library/papers/32100245PubMed
30007321SecA inhibitors as potential antimicrobial agents: differential actions on SecA-only and SecA-SecYEG protein-conducting channels.FEMS Microbiol Lett2018https://conductscience.org/library/papers/30007321PubMed
29305616Inhibitors of protein translocation across membranes of the secretory pathway: novel antimicrobial and anticancer agents.Cell Mol Life Sci2018https://conductscience.org/library/papers/29305616PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28041832

GET https://conductscience.org/api/papers/v1/28041832/authors